{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "08",
                "@year": "2021",
                "@timestamp": "2021-09-08T23:52:38.000038-04:00",
                "@month": "09"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2020",
                "@month": "05"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Chulalongkorn Academic Advancement"},
                {
                    "xocs:funding-agency-matched-string": "PERDO",
                    "xocs:funding-id": "SB-60-003-03"
                },
                {"xocs:funding-agency-matched-string": "Ratchadapisek Sompotch Fund"},
                {"xocs:funding-agency-matched-string": "S&T Postgraduate Education and Research Development Office"},
                {
                    "xocs:funding-agency-matched-string": "Chulalongkorn University",
                    "xocs:funding-agency-acronym": "CU",
                    "xocs:funding-agency": "Chulalongkorn University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Faculty of Medicine, Chulalongkorn University",
                    "xocs:funding-agency": "Faculty of Medicine, Chulalongkorn University",
                    "xocs:funding-id": "RA61/123",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004776",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2021-05-27T16:01:40.662Z",
            "xocs:funding-text": "This review was partly funded by the Center of Excellence on Medical Biotechnology (CEMB), S&T Postgraduate Education and Research Development Office (PERDO) (SB-60-003-03), Ratchadapisek Sompotch Fund, Faculty of Medicine, Chulalongkorn University (RA61/123) as well as by Chulalongkorn Academic Advancement (2nd Century Project-CUAASC). PP is supported by Postdoctoral Fellowship from the Ratchadapisek Sompotch Fund, Chulalongkorn University.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": {
                    "affiliation": {
                        "country": "Thailand",
                        "@afid": "60028190",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Faculty of Medicine"},
                            {"$": "Center of Excellence in Vaccine Research and Development"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "affiliation-id": {"@afid": "60028190"},
                        "@affiliation-instance-id": "2004440493-33430a0449e7448a0def32c863edfdf8",
                        "ce:source-text": "Faculty of Medicine, Center of Excellence in Vaccine Research and Development, Chulalongkorn University, Bangkok, Thailand"
                    },
                    "author": [
                        {
                            "ce:given-name": "Phornsiri",
                            "preferred-name": {
                                "ce:given-name": "Phornsiri",
                                "ce:initials": "P.",
                                "ce:surname": "Pechsrichuang",
                                "ce:indexed-name": "Pechsrichuang P."
                            },
                            "@seq": "1",
                            "@author-instance-id": "2004440493-e8b7668f1bffdb8fea01d4ce637ff3c9",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Pechsrichuang",
                            "@auid": "35345609300",
                            "ce:indexed-name": "Pechsrichuang P."
                        },
                        {
                            "ce:given-name": "Alain",
                            "preferred-name": {
                                "ce:given-name": "Alain",
                                "ce:initials": "A.",
                                "ce:surname": "Jacquet",
                                "ce:indexed-name": "Jacquet A."
                            },
                            "@seq": "2",
                            "@author-instance-id": "2004440493-021834f2a4c1374c6e8cfe6561933f96",
                            "ce:initials": "A.",
                            "@date-locked": "2021-02-03T15:00:13.749",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Jacquet",
                            "@auid": "55161139100",
                            "@orcid": "0000-0002-0980-9741",
                            "ce:indexed-name": "Jacquet A."
                        }
                    ]
                },
                "citation-title": "Molecular approaches to allergen-specific immunotherapy: Are we so far from clinical implementation?",
                "abstracts": "Â© 2020 John Wiley & Sons LtdConventional allergen-specific immunotherapy (AIT), based on administrations of allergen extracts, represents up to now the unique protocol for the desensitization of allergic patients. Whereas the effectiveness of AIT was evidenced for the treatment of allergic rhinitis and allergic asthma, such strategy remains experimental for food allergies up to now. However, important issues are commonly associated with AIT as the quality of natural allergen extracts, the long duration and adverse side-effects which negatively affect successful desensitization together with the patient compliance. The rapid progression of molecular allergology made possible the quest of safer, shorter and more effective immunotherapeutic approaches. The aim of this review was to provide an update on these different innovative recombinant derivatives including their efficacy but also their limitations. Despite promising preclinical and early clinical studies, the absence of convincing data in large phase III trials precludes so far the translation of these immunotherapeutic candidates into the clinic.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Faculty of Medicine"},
                            {"$": "Center of Excellence in Vaccine Research and Development"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "ce:source-text": "Faculty of Medicine, Center of Excellence in Vaccine Research and Development, Chulalongkorn University, Bangkok, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Alain",
                        "ce:initials": "A.",
                        "ce:surname": "Jacquet",
                        "ce:indexed-name": "Jacquet A."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "allergen-specific immunotherapy",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "blocking antibodies",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "clinical trial",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "efficacy",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "hypoallergenic",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "recombinant derivatives",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "safety",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Treg",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "re"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://onlinelibrary.wiley.com/loi/13652222",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Clinical and Experimental Allergy",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "50",
                            "@issue": "5"
                        },
                        "pagerange": {
                            "@first": "543",
                            "@last": "557"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Clinical and Experimental Allergy",
                    "publicationdate": {
                        "month": "05",
                        "year": "2020",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 May 2020"
                        },
                        "day": "01"
                    },
                    "codencode": "CLEAE",
                    "sourcetitle-abbrev": "Clin. Exp. Allergy",
                    "@country": "gbr",
                    "issn": [
                        {
                            "$": "13652222",
                            "@type": "electronic"
                        },
                        {
                            "$": "09547894",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2020"},
                    "publisher": {
                        "publishername": "Blackwell Publishing Ltd",
                        "ce:e-address": {
                            "$": "info@royensoc.co.uk",
                            "@type": "email"
                        }
                    },
                    "@srcid": "20723"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "CABSCLASS",
                            "classification": [
                                {
                                    "classification-code": "86.14.1",
                                    "classification-description": "IMMUNOLOGY AND INFECTIOUS DISEASES; GENERAL CONCEPTS; Reviews"
                                },
                                {
                                    "classification-code": "86.8.2.3",
                                    "classification-description": "IMMUNOLOGY AND INFECTIOUS DISEASES; IMMUNE RESPONSE DISORDERS; Chronic Inflammation, Delayed Hypersensitivity, Contact Sensitivity; Human studies"
                                },
                                {
                                    "classification-code": "86.8.2.4",
                                    "classification-description": "IMMUNOLOGY AND INFECTIOUS DISEASES; IMMUNE RESPONSE DISORDERS; Chronic Inflammation, Delayed Hypersensitivity, Contact Sensitivity; Diagnosis and therapy"
                                }
                            ]
                        },
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "26",
                                    "classification-description": "Immunology, Serology and Transplantation"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2723"},
                                {"$": "2403"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "MEDI"},
                                {"$": "IMMU"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": {
                        "@source": "nlm",
                        "chemical": {"chemical-name": "Allergens"}
                    }}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This review was partly funded by the Center of Excellence on Medical Biotechnology (CEMB), S&T Postgraduate Education and Research Development Office (PERDO) (SB-60-003-03), Ratchadapisek Sompotch Fund, Faculty of Medicine, Chulalongkorn University (RA61/123) as well as by Chulalongkorn Academic Advancement (2nd Century Project-CUAASC). PP is supported by Postdoctoral Fellowship from the Ratchadapisek Sompotch Fund, Chulalongkorn University.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2020 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Data-Review",
                "dbcollection": [
                    {"$": "CABS"},
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "27",
                    "@year": "2020",
                    "@timestamp": "BST 03:39:00",
                    "@month": "10"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2004440493",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "631012395",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "2020096963",
                            "@idtype": "CABS"
                        },
                        {
                            "$": "924779029",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20200227126",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "32078207",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20200609145",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20200896968",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20200000891464",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85081667499",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85081667499",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "631012395",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76745099",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1111/cea.13588"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "105",
                "reference": [
                    {
                        "ref-fulltext": "Casale TB, Stokes JR. Immunotherapy: What lies beyond. J Allergy Clin Immunol. 2014;133:612-619.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Immunotherapy: What lies beyond"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84896860365",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "133"},
                                "pagerange": {
                                    "@first": "612",
                                    "@last": "619"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Casale",
                                    "ce:indexed-name": "Casale T.B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Stokes",
                                    "ce:indexed-name": "Stokes J.R."
                                }
                            ]},
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Casale TB, Stokes JR. Immunotherapy: What lies beyond. J Allergy Clin Immunol. 2014;133:612-619."
                    },
                    {
                        "ref-fulltext": "Pajno GB, Fernandez-Rivas M, Arasi S, et al. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018;73:799-815.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85038248175",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "799",
                                    "@last": "815"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Pajno",
                                        "ce:indexed-name": "Pajno G.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Fernandez-Rivas",
                                        "ce:indexed-name": "Fernandez-Rivas M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Arasi",
                                        "ce:indexed-name": "Arasi S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Pajno GB, Fernandez-Rivas M, Arasi S, et al. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018;73:799-815."
                    },
                    {
                        "ref-fulltext": "Shamji MH, Durham SR. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J Allergy Clin Immunol. 2017;140:1485-1498.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85035134690",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "140"},
                                "pagerange": {
                                    "@first": "1485",
                                    "@last": "1498"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Shamji",
                                    "ce:indexed-name": "Shamji M.H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Durham",
                                    "ce:indexed-name": "Durham S.R."
                                }
                            ]},
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Shamji MH, Durham SR. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J Allergy Clin Immunol. 2017;140:1485-1498."
                    },
                    {
                        "ref-fulltext": "Traidl-Hoffmann C, Mariani V, Hochrein H, et al. Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med. 2005;201:627-636.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "14244254463",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "201"},
                                "pagerange": {
                                    "@first": "627",
                                    "@last": "636"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Traidl-Hoffmann",
                                        "ce:indexed-name": "Traidl-Hoffmann C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Mariani",
                                        "ce:indexed-name": "Mariani V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Hochrein",
                                        "ce:indexed-name": "Hochrein H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Exp Med"
                        },
                        "ce:source-text": "Traidl-Hoffmann C, Mariani V, Hochrein H, et al. Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med. 2005;201:627-636."
                    },
                    {
                        "ref-fulltext": "Oeder S, Alessandrini F, Wirz OF, et al. Pollen-derived nonallergenic substances enhance Th2-induced IgE production in B cells. Allergy. 2015;70:1450-1460.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Pollen-derived nonallergenic substances enhance Th2-induced IgE production in B cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84945477077",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "70"},
                                "pagerange": {
                                    "@first": "1450",
                                    "@last": "1460"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Oeder",
                                        "ce:indexed-name": "Oeder S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Alessandrini",
                                        "ce:indexed-name": "Alessandrini F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "O.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Wirz",
                                        "ce:indexed-name": "Wirz O.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Oeder S, Alessandrini F, Wirz OF, et al. Pollen-derived nonallergenic substances enhance Th2-induced IgE production in B cells. Allergy. 2015;70:1450-1460."
                    },
                    {
                        "ref-fulltext": "Jacquet A, Robinson C. Proteolytic, lipidergic and polysaccharide molecular recognition shape innate responses to house dust mite allergens. Allergy. 2020;75:33-53.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Proteolytic, lipidergic and polysaccharide molecular recognition shape innate responses to house dust mite allergens"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85068907189",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "75"},
                                "pagerange": {
                                    "@first": "33",
                                    "@last": "53"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Jacquet",
                                    "ce:indexed-name": "Jacquet A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Robinson",
                                    "ce:indexed-name": "Robinson C."
                                }
                            ]},
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Jacquet A, Robinson C. Proteolytic, lipidergic and polysaccharide molecular recognition shape innate responses to house dust mite allergens. Allergy. 2020;75:33-53."
                    },
                    {
                        "ref-fulltext": "Valenta R, Karaulov A, Niederberger V, et al. Allergen extracts for in vivo diagnosis and treatment of allergy: Is there a future? Allergy Clin Immunol Pract. 2018;6:1845-1855.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Allergen extracts for in vivo diagnosis and treatment of allergy: Is there a future?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85054487735",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {
                                    "@first": "1845",
                                    "@last": "1855"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Valenta",
                                        "ce:indexed-name": "Valenta R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Karaulov",
                                        "ce:indexed-name": "Karaulov A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Niederberger",
                                        "ce:indexed-name": "Niederberger V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy Clin Immunol Pract"
                        },
                        "ce:source-text": "Valenta R, Karaulov A, Niederberger V, et al. Allergen extracts for in vivo diagnosis and treatment of allergy: Is there a future? Allergy Clin Immunol Pract. 2018;6:1845-1855."
                    },
                    {
                        "ref-fulltext": "Burks AW, Calderon MA, Casale T, et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol. 2013;131:1288-1296.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84876903600",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "131"},
                                "pagerange": {
                                    "@first": "1288",
                                    "@last": "1296"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Burks",
                                        "ce:indexed-name": "Burks A.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Calderon",
                                        "ce:indexed-name": "Calderon M.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Casale",
                                        "ce:indexed-name": "Casale T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Burks AW, Calderon MA, Casale T, et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol. 2013;131:1288-1296."
                    },
                    {
                        "ref-fulltext": "RÃ¸nborg S, Johnsen CR, Theilgaard S, et al. Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark. J Med Econ. 2016;19:735-741.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84961198006",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "735",
                                    "@last": "741"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "RÃ¸nborg",
                                        "ce:indexed-name": "Ronborg S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Johnsen",
                                        "ce:indexed-name": "Johnsen C.R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Theilgaard",
                                        "ce:indexed-name": "Theilgaard S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Med Econ"
                        },
                        "ce:source-text": "RÃ¸nborg S, Johnsen CR, Theilgaard S, et al. Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark. J Med Econ. 2016;19:735-741."
                    },
                    {
                        "ref-fulltext": "Ellis AK, Gagnon R, Hammerby E, Lau A. Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs? Allergy Asthma Clin Immunol. 2019;15:27.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85064964951",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {"@first": "27"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Ellis",
                                    "ce:indexed-name": "Ellis A.K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Gagnon",
                                    "ce:indexed-name": "Gagnon R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Hammerby",
                                    "ce:indexed-name": "Hammerby E."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Lau",
                                    "ce:indexed-name": "Lau A."
                                }
                            ]},
                            "ref-sourcetitle": "Allergy Asthma Clin Immunol"
                        },
                        "ce:source-text": "Ellis AK, Gagnon R, Hammerby E, Lau A. Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs? Allergy Asthma Clin Immunol. 2019;15:27."
                    },
                    {
                        "ref-fulltext": "Pauli G, Larsen TH, Rak S, et al. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2008;122:951-960.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "49149107253",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "122"},
                                "pagerange": {
                                    "@first": "951",
                                    "@last": "960"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Pauli",
                                        "ce:indexed-name": "Pauli G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Larsen",
                                        "ce:indexed-name": "Larsen T.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rak",
                                        "ce:indexed-name": "Rak S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Pauli G, Larsen TH, Rak S, et al. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2008;122:951-960."
                    },
                    {
                        "ref-fulltext": "Nony E, Bouley J, Le Mignon M, et al. Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients. Allergy. 2015;70:795-804.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84931562545",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "70"},
                                "pagerange": {
                                    "@first": "795",
                                    "@last": "804"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Nony",
                                        "ce:indexed-name": "Nony E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Bouley",
                                        "ce:indexed-name": "Bouley J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Le Mignon",
                                        "ce:indexed-name": "Le Mignon M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Nony E, Bouley J, Le Mignon M, et al. Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients. Allergy. 2015;70:795-804."
                    },
                    {
                        "ref-fulltext": "Kinaciyan T, Nagl B, Faustmann S, et al. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen\u2013related apple allergy. J Allergy Clin Immunol. 2018;141:1002-1008.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen\u2013related apple allergy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85030462411",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "141"},
                                "pagerange": {
                                    "@first": "1002",
                                    "@last": "1008"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Kinaciyan",
                                        "ce:indexed-name": "Kinaciyan T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Nagl",
                                        "ce:indexed-name": "Nagl B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Faustmann",
                                        "ce:indexed-name": "Faustmann S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Kinaciyan T, Nagl B, Faustmann S, et al. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen\u2013related apple allergy. J Allergy Clin Immunol. 2018;141:1002-1008."
                    },
                    {
                        "ref-fulltext": "MÃ¼ller U, Akdis CA, Fricker M, et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol. 1998;101:747-754.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1998"},
                            "ref-title": {"ref-titletext": "Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0031866059",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "101"},
                                "pagerange": {
                                    "@first": "747",
                                    "@last": "754"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "U.",
                                        "@_fa": "true",
                                        "ce:surname": "MÃ¼ller",
                                        "ce:indexed-name": "Muller U."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Akdis",
                                        "ce:indexed-name": "Akdis C.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Fricker",
                                        "ce:indexed-name": "Fricker M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "MÃ¼ller U, Akdis CA, Fricker M, et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol. 1998;101:747-754."
                    },
                    {
                        "ref-fulltext": "Ellis AK, Frankish CW, O'Hehir RE, et al. Treatment with grass allergen peptides improves symptoms of grass pollen\u2013induced allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2017;140:486-496.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Treatment with grass allergen peptides improves symptoms of grass pollen\u2013induced allergic rhinoconjunctivitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0015",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85013434308",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "140"},
                                "pagerange": {
                                    "@first": "486",
                                    "@last": "496"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Ellis",
                                        "ce:indexed-name": "Ellis A.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Frankish",
                                        "ce:indexed-name": "Frankish C.W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.E.",
                                        "@_fa": "true",
                                        "ce:surname": "O'Hehir",
                                        "ce:indexed-name": "O'Hehir R.E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Ellis AK, Frankish CW, O'Hehir RE, et al. Treatment with grass allergen peptides improves symptoms of grass pollen\u2013induced allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2017;140:486-496."
                    },
                    {
                        "ref-fulltext": "Couroux P, Patel D, Armstrong K, LarchÃ© M, Hafner RP. Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects. Clin Exp Allergy. 2015;45:974-981.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0016",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84927775059",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "974",
                                    "@last": "981"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Couroux",
                                    "ce:indexed-name": "Couroux P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Patel",
                                    "ce:indexed-name": "Patel D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Armstrong",
                                    "ce:indexed-name": "Armstrong K."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "LarchÃ©",
                                    "ce:indexed-name": "Larche M."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "R.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Hafner",
                                    "ce:indexed-name": "Hafner R.P."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Exp Allergy"
                        },
                        "ce:source-text": "Couroux P, Patel D, Armstrong K, LarchÃ© M, Hafner RP. Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects. Clin Exp Allergy. 2015;45:974-981."
                    },
                    {
                        "ref-fulltext": "Hafner R, Couroux P, Armstrong K, Salapatek AM, Patel D, LarchÃ© M. Persistent treatment effect achieved at one year after four doses of Der p derived synthetic peptide immuno-regulatory epitopes in an exposure chamber model of house dust mite allergy. J Allergy Clin Immunol. 2014;133:AB289.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Persistent treatment effect achieved at one year after four doses of Der p derived synthetic peptide immuno-regulatory epitopes in an exposure chamber model of house dust mite allergy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0017",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84919595320",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "133"},
                                "pagerange": {"@first": "AB289"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Hafner",
                                    "ce:indexed-name": "Hafner R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Couroux",
                                    "ce:indexed-name": "Couroux P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Armstrong",
                                    "ce:indexed-name": "Armstrong K."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Salapatek",
                                    "ce:indexed-name": "Salapatek A.M."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Patel",
                                    "ce:indexed-name": "Patel D."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "LarchÃ©",
                                    "ce:indexed-name": "Larche M."
                                }
                            ]},
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Hafner R, Couroux P, Armstrong K, Salapatek AM, Patel D, LarchÃ© M. Persistent treatment effect achieved at one year after four doses of Der p derived synthetic peptide immuno-regulatory epitopes in an exposure chamber model of house dust mite allergy. J Allergy Clin Immunol. 2014;133:AB289."
                    },
                    {
                        "ref-fulltext": "Circassia announces top-line results from house dust mite allergy field study. http://www.circassia.com/media/press-releases/circassia-announces-top-line-results-from-house-dust-mite-allergy-field-study. Accessed April 18, 2017.",
                        "@id": "18",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.circassia.com/media/press-releases/circassia-announces-top-line-results-from-house-dust-mite-allergy-field-study",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0018",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85081681048",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Accessed April 18, 2017",
                            "ref-sourcetitle": "Circassia announces top-line results from house dust mite allergy field study"
                        },
                        "ce:source-text": "Circassia announces top-line results from house dust mite allergy field study. http://www.circassia.com/media/press-releases/circassia-announces-top-line-results-from-house-dust-mite-allergy-field-study. Accessed April 18, 2017."
                    },
                    {
                        "ref-fulltext": "Spertini F, DellaCorte G, Kettner A, et al. Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1 derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study. J Allergy Clin Immunol. 2016;138:162-168.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1 derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0019",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84991011441",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "138"},
                                "pagerange": {
                                    "@first": "162",
                                    "@last": "168"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Spertini",
                                        "ce:indexed-name": "Spertini F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "DellaCorte",
                                        "ce:indexed-name": "DellaCorte G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Kettner",
                                        "ce:indexed-name": "Kettner A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Spertini F, DellaCorte G, Kettner A, et al. Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1 derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study. J Allergy Clin Immunol. 2016;138:162-168."
                    },
                    {
                        "ref-fulltext": "MÃ¶sges R, Bachert C, Panzner P, et al. Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial. Allergy. 2018;73:1842-1850.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0020",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85052753982",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "1842",
                                    "@last": "1850"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "MÃ¶sges",
                                        "ce:indexed-name": "Mosges R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Bachert",
                                        "ce:indexed-name": "Bachert C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Panzner",
                                        "ce:indexed-name": "Panzner P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "MÃ¶sges R, Bachert C, Panzner P, et al. Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial. Allergy. 2018;73:1842-1850."
                    },
                    {
                        "ref-fulltext": "Pfaar O, Urry Z, Robinson DS, et al. A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy. Allergy. 2012;67:272-279.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0021",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84855791137",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {
                                    "@first": "272",
                                    "@last": "279"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "O.",
                                        "@_fa": "true",
                                        "ce:surname": "Pfaar",
                                        "ce:indexed-name": "Pfaar O."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Urry",
                                        "ce:indexed-name": "Urry Z."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Robinson",
                                        "ce:indexed-name": "Robinson D.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Pfaar O, Urry Z, Robinson DS, et al. A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy. Allergy. 2012;67:272-279."
                    },
                    {
                        "ref-fulltext": "Sharif H, Singh I, Kouser L, et al. Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2019;144:738-749.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0022",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85063746362",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "144"},
                                "pagerange": {
                                    "@first": "738",
                                    "@last": "749"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Sharif",
                                        "ce:indexed-name": "Sharif H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Singh",
                                        "ce:indexed-name": "Singh I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Kouser",
                                        "ce:indexed-name": "Kouser L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Sharif H, Singh I, Kouser L, et al. Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2019;144:738-749."
                    },
                    {
                        "ref-fulltext": "ASIT biotech publishes the results of the hdm-ASIT+â¢ Phase I/II follow-up study in house dust mite rhinitis. https://www.asitbiotech.com/images/gb/pdf/PR_ASIT_hdm_results_follow-up_final_EN.pdf. Accessed October 24, 2017.",
                        "@id": "23",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.asitbiotech.com/images/gb/pdf/PR_ASIT_hdm_results_follow-up_final_EN.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0023",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85081659440",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Accessed October 24, 2017",
                            "ref-sourcetitle": "ASIT biotech publishes the results of the hdm-ASIT+â¢ Phase I/II follow-up study in house dust mite rhinitis"
                        },
                        "ce:source-text": "ASIT biotech publishes the results of the hdm-ASIT+â¢ Phase I/II follow-up study in house dust mite rhinitis. https://www.asitbiotech.com/images/gb/pdf/PR_ASIT_hdm_results_follow-up_final_EN.pdf. Accessed October 24, 2017."
                    },
                    {
                        "ref-fulltext": "Focke-Tejkl M, Weber M, Niespodziana K, et al. Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy. J Allergy Clin Immunol. 2015;135:1207-1217.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0024",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84943452181",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "135"},
                                "pagerange": {
                                    "@first": "1207",
                                    "@last": "1217"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Focke-Tejkl",
                                        "ce:indexed-name": "Focke-Tejkl M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Weber",
                                        "ce:indexed-name": "Weber M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Niespodziana",
                                        "ce:indexed-name": "Niespodziana K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Focke-Tejkl M, Weber M, Niespodziana K, et al. Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy. J Allergy Clin Immunol. 2015;135:1207-1217."
                    },
                    {
                        "ref-fulltext": "Zieglmayer P, Focke-Tejkl M, Schmutz R, et al. Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy. EBioMedicine. 2016;11:43-57.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0025",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84994807376",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "43",
                                    "@last": "57"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Zieglmayer",
                                        "ce:indexed-name": "Zieglmayer P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Focke-Tejkl",
                                        "ce:indexed-name": "Focke-Tejkl M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Schmutz",
                                        "ce:indexed-name": "Schmutz R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "EBioMedicine"
                        },
                        "ce:source-text": "Zieglmayer P, Focke-Tejkl M, Schmutz R, et al. Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy. EBioMedicine. 2016;11:43-57."
                    },
                    {
                        "ref-fulltext": "Niederberger V, Neubauer A, Gevaert P, et al. Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32. J Allergy Clin Immunol. 2018;142:497-509.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0026",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85041122135",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "142"},
                                "pagerange": {
                                    "@first": "497",
                                    "@last": "509"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Niederberger",
                                        "ce:indexed-name": "Niederberger V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Neubauer",
                                        "ce:indexed-name": "Neubauer A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Gevaert",
                                        "ce:indexed-name": "Gevaert P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Niederberger V, Neubauer A, Gevaert P, et al. Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32. J Allergy Clin Immunol. 2018;142:497-509."
                    },
                    {
                        "ref-fulltext": "Rauber MM, MÃ¶bs C, Campana R, et al. Allergen immunotherapy with the hypoallergenic B-cell epitope-based vaccine BM32 modifies IL-10- and IL-5-secreting T cells. Allergy. 2020;75(2):450\u2013453.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Allergen immunotherapy with the hypoallergenic B-cell epitope-based vaccine BM32 modifies IL-10- and IL-5-secreting T cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0027",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85071525864",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "75",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "450",
                                    "@last": "453"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Rauber",
                                        "ce:indexed-name": "Rauber M.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "MÃ¶bs",
                                        "ce:indexed-name": "Mobs C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Campana",
                                        "ce:indexed-name": "Campana R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Rauber MM, MÃ¶bs C, Campana R, et al. Allergen immunotherapy with the hypoallergenic B-cell epitope-based vaccine BM32 modifies IL-10- and IL-5-secreting T cells. Allergy. 2020;75(2):450\u2013453."
                    },
                    {
                        "ref-fulltext": "Satitsuksanoa P, Globinska A, Jansen K, van de Veen W, Akdis M. Modified Allergens for immunotherapy. Curr Allergy Asthma Rep. 2018;18:9.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Modified Allergens for immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0028",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85042237100",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {"@first": "9"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Satitsuksanoa",
                                    "ce:indexed-name": "Satitsuksanoa P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Globinska",
                                    "ce:indexed-name": "Globinska A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Jansen",
                                    "ce:indexed-name": "Jansen K."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "van de Veen",
                                    "ce:indexed-name": "van de Veen W."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Akdis",
                                    "ce:indexed-name": "Akdis M."
                                }
                            ]},
                            "ref-sourcetitle": "Curr Allergy Asthma Rep"
                        },
                        "ce:source-text": "Satitsuksanoa P, Globinska A, Jansen K, van de Veen W, Akdis M. Modified Allergens for immunotherapy. Curr Allergy Asthma Rep. 2018;18:9."
                    },
                    {
                        "ref-fulltext": "Zimmer J, Bonertz A, Vieths S. Quality requirements for allergen extracts and allergoids for allergen immunotherapy. Allergol Immunopathol. 2017;45(Suppl 1):4-11.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Quality requirements for allergen extracts and allergoids for allergen immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0029",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85033406116",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "4",
                                    "@last": "11"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Zimmer",
                                    "ce:indexed-name": "Zimmer J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Bonertz",
                                    "ce:indexed-name": "Bonertz A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Vieths",
                                    "ce:indexed-name": "Vieths S."
                                }
                            ]},
                            "ref-sourcetitle": "Allergol Immunopathol"
                        },
                        "ce:source-text": "Zimmer J, Bonertz A, Vieths S. Quality requirements for allergen extracts and allergoids for allergen immunotherapy. Allergol Immunopathol. 2017;45(Suppl 1):4-11."
                    },
                    {
                        "ref-fulltext": "Jacquet A. Perspectives in allergen-specific immunotherapy: molecular evolution of peptide- and protein-based strategies. Curr Protein Pept Sci. 2019;20. https://doi.org/10.2174/1389203720666190718152534.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.2174/1389203720666190718152534",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Perspectives in allergen-specific immunotherapy: molecular evolution of peptide- and protein-based strategies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0030",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85081646277",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "20"}},
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "ce:surname": "Jacquet",
                                "ce:indexed-name": "Jacquet A."
                            }]},
                            "ref-sourcetitle": "Curr Protein Pept Sci"
                        },
                        "ce:source-text": "Jacquet A. Perspectives in allergen-specific immunotherapy: molecular evolution of peptide- and protein-based strategies. Curr Protein Pept Sci. 2019;20. https://doi.org/10.2174/1389203720666190718152534."
                    },
                    {
                        "ref-fulltext": "Niederberger V, Horak F, Vrtala S, et al. Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci. 2004;101:14677-14682.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Vaccination with genetically engineered allergens prevents progression of allergic disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0031",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "5144222703",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "101"},
                                "pagerange": {
                                    "@first": "14677",
                                    "@last": "14682"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Niederberger",
                                        "ce:indexed-name": "Niederberger V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Horak",
                                        "ce:indexed-name": "Horak F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Vrtala",
                                        "ce:indexed-name": "Vrtala S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Proc Natl Acad Sci"
                        },
                        "ce:source-text": "Niederberger V, Horak F, Vrtala S, et al. Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci. 2004;101:14677-14682."
                    },
                    {
                        "ref-fulltext": "Purohit A, Niederberger V, Kronqvist M, et al. Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives. Clin Exp Allergy. 2008;38:1514-1525.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0032",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "46849121475",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "38"},
                                "pagerange": {
                                    "@first": "1514",
                                    "@last": "1525"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Purohit",
                                        "ce:indexed-name": "Purohit A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Niederberger",
                                        "ce:indexed-name": "Niederberger V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kronqvist",
                                        "ce:indexed-name": "Kronqvist M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Exp Allergy"
                        },
                        "ce:source-text": "Purohit A, Niederberger V, Kronqvist M, et al. Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives. Clin Exp Allergy. 2008;38:1514-1525."
                    },
                    {
                        "ref-fulltext": "Campana R, Marth K, Zieglmayer P, et al. Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms. J Allergy Clin Immunol. 2019;143:1258-1261.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0033",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85059514719",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "143"},
                                "pagerange": {
                                    "@first": "1258",
                                    "@last": "1261"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Campana",
                                        "ce:indexed-name": "Campana R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Marth",
                                        "ce:indexed-name": "Marth K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Zieglmayer",
                                        "ce:indexed-name": "Zieglmayer P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Campana R, Marth K, Zieglmayer P, et al. Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms. J Allergy Clin Immunol. 2019;143:1258-1261."
                    },
                    {
                        "ref-fulltext": "Klimek L, Bachert C, Lukat KF, Pfaar O, Meyer H, Narkus A. Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial. Clin Transl Allergy. 2015;5:28.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0034",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85006106365",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {"@first": "28"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Klimek",
                                    "ce:indexed-name": "Klimek L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Bachert",
                                    "ce:indexed-name": "Bachert C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Lukat",
                                    "ce:indexed-name": "Lukat K.F."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "O.",
                                    "@_fa": "true",
                                    "ce:surname": "Pfaar",
                                    "ce:indexed-name": "Pfaar O."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Meyer",
                                    "ce:indexed-name": "Meyer H."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Narkus",
                                    "ce:indexed-name": "Narkus A."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Transl Allergy"
                        },
                        "ce:source-text": "Klimek L, Bachert C, Lukat KF, Pfaar O, Meyer H, Narkus A. Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial. Clin Transl Allergy. 2015;5:28."
                    },
                    {
                        "ref-fulltext": "Wood RA, Sicherer SH, Burks AW, Grishin A, Henning AK, Lindblad R. A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy. Allergy. 2013;68:803-808.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0035",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84878108455",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "68"},
                                "pagerange": {
                                    "@first": "803",
                                    "@last": "808"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Wood",
                                    "ce:indexed-name": "Wood R.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Sicherer",
                                    "ce:indexed-name": "Sicherer S.H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Burks",
                                    "ce:indexed-name": "Burks A.W."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Grishin",
                                    "ce:indexed-name": "Grishin A."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Henning",
                                    "ce:indexed-name": "Henning A.K."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Lindblad",
                                    "ce:indexed-name": "Lindblad R."
                                }
                            ]},
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Wood RA, Sicherer SH, Burks AW, Grishin A, Henning AK, Lindblad R. A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy. Allergy. 2013;68:803-808."
                    },
                    {
                        "ref-fulltext": "Scheiblhofer S, Thalhamer J, Weiss R. DNA and mRNA vaccination against allergies. Pediatr Allergy Immunol. 2018;29:679-688.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "DNA and mRNA vaccination against allergies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0036",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85053508195",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "679",
                                    "@last": "688"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Scheiblhofer",
                                    "ce:indexed-name": "Scheiblhofer S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Thalhamer",
                                    "ce:indexed-name": "Thalhamer J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Weiss",
                                    "ce:indexed-name": "Weiss R."
                                }
                            ]},
                            "ref-sourcetitle": "Pediatr Allergy Immunol"
                        },
                        "ce:source-text": "Scheiblhofer S, Thalhamer J, Weiss R. DNA and mRNA vaccination against allergies. Pediatr Allergy Immunol. 2018;29:679-688."
                    },
                    {
                        "ref-fulltext": "Su Y, Romeu-Bonilla E, Anagnostou A, Fitz-Patrick D, Hearl W, Heiland T. Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: A phase I study. Hum Vaccin Immunother. 2017;13:2804-2813.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: A phase I study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0037",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85021287019",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "2804",
                                    "@last": "2813"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Su",
                                    "ce:indexed-name": "Su Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Romeu-Bonilla",
                                    "ce:indexed-name": "Romeu-Bonilla E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Anagnostou",
                                    "ce:indexed-name": "Anagnostou A."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Fitz-Patrick",
                                    "ce:indexed-name": "Fitz-Patrick D."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Hearl",
                                    "ce:indexed-name": "Hearl W."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Heiland",
                                    "ce:indexed-name": "Heiland T."
                                }
                            ]},
                            "ref-sourcetitle": "Hum Vaccin Immunother"
                        },
                        "ce:source-text": "Su Y, Romeu-Bonilla E, Anagnostou A, Fitz-Patrick D, Hearl W, Heiland T. Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: A phase I study. Hum Vaccin Immunother. 2017;13:2804-2813."
                    },
                    {
                        "ref-fulltext": "Hattinger E, Scheiblhofer S, Roesler E, Thalhamer T, Thalhamer J, Weiss R. Prophylactic mRNA vaccination against allergy confers long-term memory responses and persistent protection in mice. J Immunol Res. 2015;2015:1\u201312.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Prophylactic mRNA vaccination against allergy confers long-term memory responses and persistent protection in mice"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0038",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84947087001",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2015"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "12"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Hattinger",
                                    "ce:indexed-name": "Hattinger E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Scheiblhofer",
                                    "ce:indexed-name": "Scheiblhofer S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Roesler",
                                    "ce:indexed-name": "Roesler E."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Thalhamer",
                                    "ce:indexed-name": "Thalhamer T."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Thalhamer",
                                    "ce:indexed-name": "Thalhamer J."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Weiss",
                                    "ce:indexed-name": "Weiss R."
                                }
                            ]},
                            "ref-sourcetitle": "J Immunol Res"
                        },
                        "ce:source-text": "Hattinger E, Scheiblhofer S, Roesler E, Thalhamer T, Thalhamer J, Weiss R. Prophylactic mRNA vaccination against allergy confers long-term memory responses and persistent protection in mice. J Immunol Res. 2015;2015:1\u201312."
                    },
                    {
                        "ref-fulltext": "Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discovery. 2018;17:261-279.",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "mRNA vaccines - a new era in vaccinology"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0039",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85044634269",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "261",
                                    "@last": "279"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Pardi",
                                    "ce:indexed-name": "Pardi N."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Hogan",
                                    "ce:indexed-name": "Hogan M.J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "F.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Porter",
                                    "ce:indexed-name": "Porter F.W."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Weissman",
                                    "ce:indexed-name": "Weissman D."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Rev Drug Discovery"
                        },
                        "ce:source-text": "Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discovery. 2018;17:261-279."
                    },
                    {
                        "ref-fulltext": "Anzaghe M, SchÃ¼lke S, Scheurer S. Virus-like particles as carrier systems to enhance immunomodulation in allergen immunotherapy. Curr Allergy Asthma Rep. 2018;18:71.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Virus-like particles as carrier systems to enhance immunomodulation in allergen immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0040",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85055613112",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {"@first": "71"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Anzaghe",
                                    "ce:indexed-name": "Anzaghe M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "SchÃ¼lke",
                                    "ce:indexed-name": "Schulke S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Scheurer",
                                    "ce:indexed-name": "Scheurer S."
                                }
                            ]},
                            "ref-sourcetitle": "Curr Allergy Asthma Rep"
                        },
                        "ce:source-text": "Anzaghe M, SchÃ¼lke S, Scheurer S. Virus-like particles as carrier systems to enhance immunomodulation in allergen immunotherapy. Curr Allergy Asthma Rep. 2018;18:71."
                    },
                    {
                        "ref-fulltext": "Zabel F, Mohanan D, Bessa J, et al. Viral particles drive rapid differentiation of memory B cells into secondary plasma cells producing increased levels of antibodies. J Immunol. 2014;192:5499-5508.",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Viral particles drive rapid differentiation of memory B cells into secondary plasma cells producing increased levels of antibodies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0041",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84902170182",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "192"},
                                "pagerange": {
                                    "@first": "5499",
                                    "@last": "5508"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Zabel",
                                        "ce:indexed-name": "Zabel F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Mohanan",
                                        "ce:indexed-name": "Mohanan D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Bessa",
                                        "ce:indexed-name": "Bessa J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Immunol"
                        },
                        "ce:source-text": "Zabel F, Mohanan D, Bessa J, et al. Viral particles drive rapid differentiation of memory B cells into secondary plasma cells producing increased levels of antibodies. J Immunol. 2014;192:5499-5508."
                    },
                    {
                        "ref-fulltext": "Klimek L, Kundig T, Kramer MF, et al. Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases. Allergo J Int. 2018;27:245-255.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0042",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85051057677",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "245",
                                    "@last": "255"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Klimek",
                                        "ce:indexed-name": "Klimek L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Kundig",
                                        "ce:indexed-name": "Kundig T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Kramer",
                                        "ce:indexed-name": "Kramer M.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergo J Int"
                        },
                        "ce:source-text": "Klimek L, Kundig T, Kramer MF, et al. Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases. Allergo J Int. 2018;27:245-255."
                    },
                    {
                        "ref-fulltext": "Chackerian B, Lowy DR, Schiller JT. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J Clin Invest. 2001;108:415-423.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0043",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0034898470",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "108"},
                                "pagerange": {
                                    "@first": "415",
                                    "@last": "423"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Chackerian",
                                    "ce:indexed-name": "Chackerian B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Lowy",
                                    "ce:indexed-name": "Lowy D.R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Schiller",
                                    "ce:indexed-name": "Schiller J.T."
                                }
                            ]},
                            "ref-sourcetitle": "J Clin Invest"
                        },
                        "ce:source-text": "Chackerian B, Lowy DR, Schiller JT. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J Clin Invest. 2001;108:415-423."
                    },
                    {
                        "ref-fulltext": "Engeroff P, Caviezel F, Storni F, Thoms F, Vogel M, Bachmann MF. Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells. Allergy. 2018;73:341-349.",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0044",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85030033666",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "341",
                                    "@last": "349"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Engeroff",
                                    "ce:indexed-name": "Engeroff P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Caviezel",
                                    "ce:indexed-name": "Caviezel F."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Storni",
                                    "ce:indexed-name": "Storni F."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Thoms",
                                    "ce:indexed-name": "Thoms F."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Vogel",
                                    "ce:indexed-name": "Vogel M."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "M.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Bachmann",
                                    "ce:indexed-name": "Bachmann M.F."
                                }
                            ]},
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Engeroff P, Caviezel F, Storni F, Thoms F, Vogel M, Bachmann MF. Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells. Allergy. 2018;73:341-349."
                    },
                    {
                        "ref-fulltext": "Soongrung T, Mongkorntanyatip K, Peepim T, et al. Virus like particles displaying major HDM allergen Der p 2 for prophylactic allergen immunotherapy. Allergy. 2019. https://doi.org/10.1111/all.14096.",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1111/all.14096",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Virus like particles displaying major HDM allergen Der p 2 for prophylactic allergen immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0045",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079035273",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Soongrung",
                                        "ce:indexed-name": "Soongrung T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Mongkorntanyatip",
                                        "ce:indexed-name": "Mongkorntanyatip K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Peepim",
                                        "ce:indexed-name": "Peepim T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Soongrung T, Mongkorntanyatip K, Peepim T, et al. Virus like particles displaying major HDM allergen Der p 2 for prophylactic allergen immunotherapy. Allergy. 2019. https://doi.org/10.1111/all.14096."
                    },
                    {
                        "ref-fulltext": "Storni F, Zeltins A, Balke I, et al. Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens. J Allergy Clin Immunol. 2019;6749:31709-31719.",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0046",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079537779",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6749"},
                                "pagerange": {
                                    "@first": "31709",
                                    "@last": "31719"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Storni",
                                        "ce:indexed-name": "Storni F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Zeltins",
                                        "ce:indexed-name": "Zeltins A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Balke",
                                        "ce:indexed-name": "Balke I."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Storni F, Zeltins A, Balke I, et al. Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens. J Allergy Clin Immunol. 2019;6749:31709-31719."
                    },
                    {
                        "ref-fulltext": "KÃ¼ndig TM, Senti G, Schnetzler G, et al. Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. J Allergy Clin Immunol. 2006;117:1470-1476.",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0047",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33646949257",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "117"},
                                "pagerange": {
                                    "@first": "1470",
                                    "@last": "1476"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.M.",
                                        "@_fa": "true",
                                        "ce:surname": "KÃ¼ndig",
                                        "ce:indexed-name": "Kundig T.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Senti",
                                        "ce:indexed-name": "Senti G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Schnetzler",
                                        "ce:indexed-name": "Schnetzler G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "KÃ¼ndig TM, Senti G, Schnetzler G, et al. Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. J Allergy Clin Immunol. 2006;117:1470-1476."
                    },
                    {
                        "ref-fulltext": "Senti G, Johansen P, Haug S, et al. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. Clin Exp Allergy. 2009;39:562-570.",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0048",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "62449179406",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "39"},
                                "pagerange": {
                                    "@first": "562",
                                    "@last": "570"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Senti",
                                        "ce:indexed-name": "Senti G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Johansen",
                                        "ce:indexed-name": "Johansen P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Haug",
                                        "ce:indexed-name": "Haug S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Exp Allergy"
                        },
                        "ce:source-text": "Senti G, Johansen P, Haug S, et al. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. Clin Exp Allergy. 2009;39:562-570."
                    },
                    {
                        "ref-fulltext": "Klimek L, Willers J, Hammann-Haenni A, et al. Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study. Clin Exp Allergy. 2011;41:1305-1312.",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0049",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "80051794923",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "1305",
                                    "@last": "1312"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Klimek",
                                        "ce:indexed-name": "Klimek L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Willers",
                                        "ce:indexed-name": "Willers J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Hammann-Haenni",
                                        "ce:indexed-name": "Hammann-Haenni A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Exp Allergy"
                        },
                        "ce:source-text": "Klimek L, Willers J, Hammann-Haenni A, et al. Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study. Clin Exp Allergy. 2011;41:1305-1312."
                    },
                    {
                        "ref-fulltext": "Beeh KM, Kanniess F, Wagner F, et al. The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma. J Allergy Clin Immunol. 2013;131:866-874.",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0050",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84875219804",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "131"},
                                "pagerange": {
                                    "@first": "866",
                                    "@last": "874"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Beeh",
                                        "ce:indexed-name": "Beeh K.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Kanniess",
                                        "ce:indexed-name": "Kanniess F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Wagner",
                                        "ce:indexed-name": "Wagner F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Beeh KM, Kanniess F, Wagner F, et al. The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma. J Allergy Clin Immunol. 2013;131:866-874."
                    },
                    {
                        "ref-fulltext": "Thoms F, Jennings GT, Maudrich M, et al. Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects. J Allergy Clin Immunol. 2019;144:193-203.",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0051",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85067792052",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "144"},
                                "pagerange": {
                                    "@first": "193",
                                    "@last": "203"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Thoms",
                                        "ce:indexed-name": "Thoms F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Jennings",
                                        "ce:indexed-name": "Jennings G.T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Maudrich",
                                        "ce:indexed-name": "Maudrich M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Thoms F, Jennings GT, Maudrich M, et al. Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects. J Allergy Clin Immunol. 2019;144:193-203."
                    },
                    {
                        "ref-fulltext": "Fettelschoss-Gabriel A, Fettelschoss V, Olomski F, et al. Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses. Allergy. 2019;74:572-582.",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0052",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85055782464",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "74"},
                                "pagerange": {
                                    "@first": "572",
                                    "@last": "582"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Fettelschoss-Gabriel",
                                        "ce:indexed-name": "Fettelschoss-Gabriel A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Fettelschoss",
                                        "ce:indexed-name": "Fettelschoss V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Olomski",
                                        "ce:indexed-name": "Olomski F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Fettelschoss-Gabriel A, Fettelschoss V, Olomski F, et al. Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses. Allergy. 2019;74:572-582."
                    },
                    {
                        "ref-fulltext": "Crameri R, FlÃ¼ckiger S, Daigle I, KÃ¼ndig T, Rhyner C. Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines. Allergy. 2007;62:197-206.",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0053",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33846147671",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "62"},
                                "pagerange": {
                                    "@first": "197",
                                    "@last": "206"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Crameri",
                                    "ce:indexed-name": "Crameri R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "FlÃ¼ckiger",
                                    "ce:indexed-name": "Fluckiger S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Daigle",
                                    "ce:indexed-name": "Daigle I."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "KÃ¼ndig",
                                    "ce:indexed-name": "Kundig T."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Rhyner",
                                    "ce:indexed-name": "Rhyner C."
                                }
                            ]},
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Crameri R, FlÃ¼ckiger S, Daigle I, KÃ¼ndig T, Rhyner C. Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines. Allergy. 2007;62:197-206."
                    },
                    {
                        "ref-fulltext": "Martinez-Gomez JM, Johansen P, Rose H, et al. Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy. Allergy. 2009;64:172-178.",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0054",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "58149136998",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "172",
                                    "@last": "178"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Martinez-Gomez",
                                        "ce:indexed-name": "Martinez-Gomez J.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Johansen",
                                        "ce:indexed-name": "Johansen P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Rose",
                                        "ce:indexed-name": "Rose H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Martinez-Gomez JM, Johansen P, Rose H, et al. Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy. Allergy. 2009;64:172-178."
                    },
                    {
                        "ref-fulltext": "Senti G, Crameri R, Kuster D, et al. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol. 2012;129:1290-1296.",
                        "@id": "55",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0055",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84860486360",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "129"},
                                "pagerange": {
                                    "@first": "1290",
                                    "@last": "1296"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Senti",
                                        "ce:indexed-name": "Senti G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Crameri",
                                        "ce:indexed-name": "Crameri R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Kuster",
                                        "ce:indexed-name": "Kuster D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Senti G, Crameri R, Kuster D, et al. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol. 2012;129:1290-1296."
                    },
                    {
                        "ref-fulltext": "Freiberger SN, Zehnder M, Gafvelin G, GrÃ¶nlund H, KÃ¼ndig TM, Johansen P. IgG4 but no IgG1 antibody production after intralymphatic immunotherapy with recombinant MAT-Fel d1 in human. Allergy. 2016;71:1366-1370.",
                        "@id": "56",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "IgG4 but no IgG1 antibody production after intralymphatic immunotherapy with recombinant MAT-Fel d1 in human"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0056",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84978786374",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "71"},
                                "pagerange": {
                                    "@first": "1366",
                                    "@last": "1370"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.N.",
                                    "@_fa": "true",
                                    "ce:surname": "Freiberger",
                                    "ce:indexed-name": "Freiberger S.N."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Zehnder",
                                    "ce:indexed-name": "Zehnder M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Gafvelin",
                                    "ce:indexed-name": "Gafvelin G."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "GrÃ¶nlund",
                                    "ce:indexed-name": "Gronlund H."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "T.M.",
                                    "@_fa": "true",
                                    "ce:surname": "KÃ¼ndig",
                                    "ce:indexed-name": "Kundig T.M."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Johansen",
                                    "ce:indexed-name": "Johansen P."
                                }
                            ]},
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Freiberger SN, Zehnder M, Gafvelin G, GrÃ¶nlund H, KÃ¼ndig TM, Johansen P. IgG4 but no IgG1 antibody production after intralymphatic immunotherapy with recombinant MAT-Fel d1 in human. Allergy. 2016;71:1366-1370."
                    },
                    {
                        "ref-fulltext": "Senti G, Freiburghaus AU, Larenas-Linnemann D, et al. Intralymphatic Immunotherapy: Update and Unmet Needs. Int Arch Allergy Immunol. 2019;178:141-149.",
                        "@id": "57",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Intralymphatic Immunotherapy: Update and Unmet Needs"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0057",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85056460849",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "178"},
                                "pagerange": {
                                    "@first": "141",
                                    "@last": "149"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Senti",
                                        "ce:indexed-name": "Senti G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.U.",
                                        "@_fa": "true",
                                        "ce:surname": "Freiburghaus",
                                        "ce:indexed-name": "Freiburghaus A.U."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Larenas-Linnemann",
                                        "ce:indexed-name": "Larenas-Linnemann D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int Arch Allergy Immunol"
                        },
                        "ce:source-text": "Senti G, Freiburghaus AU, Larenas-Linnemann D, et al. Intralymphatic Immunotherapy: Update and Unmet Needs. Int Arch Allergy Immunol. 2019;178:141-149."
                    },
                    {
                        "ref-fulltext": "Senti G, von Moos S, KÃ¼ndig TM. Epicutaneous allergen administration: Is this the future of allergen-specific immunotherapy? Allergy. 2011;66:798-809.",
                        "@id": "58",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Epicutaneous allergen administration: Is this the future of allergen-specific immunotherapy?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0058",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79955466306",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "66"},
                                "pagerange": {
                                    "@first": "798",
                                    "@last": "809"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Senti",
                                    "ce:indexed-name": "Senti G."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "von Moos",
                                    "ce:indexed-name": "von Moos S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.M.",
                                    "@_fa": "true",
                                    "ce:surname": "KÃ¼ndig",
                                    "ce:indexed-name": "Kundig T.M."
                                }
                            ]},
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Senti G, von Moos S, KÃ¼ndig TM. Epicutaneous allergen administration: Is this the future of allergen-specific immunotherapy? Allergy. 2011;66:798-809."
                    },
                    {
                        "ref-fulltext": "Mondoulet L, Dioszeghy V, Vanoirbeek JA, Nemery B, Dupont C, Benhamou PH. Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts. Int Arch Allergy Immunol. 2011;154:299-309.",
                        "@id": "59",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0059",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77958013242",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "154"},
                                "pagerange": {
                                    "@first": "299",
                                    "@last": "309"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Mondoulet",
                                    "ce:indexed-name": "Mondoulet L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "V.",
                                    "@_fa": "true",
                                    "ce:surname": "Dioszeghy",
                                    "ce:indexed-name": "Dioszeghy V."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Vanoirbeek",
                                    "ce:indexed-name": "Vanoirbeek J.A."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Nemery",
                                    "ce:indexed-name": "Nemery B."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Dupont",
                                    "ce:indexed-name": "Dupont C."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "P.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Benhamou",
                                    "ce:indexed-name": "Benhamou P.H."
                                }
                            ]},
                            "ref-sourcetitle": "Int Arch Allergy Immunol"
                        },
                        "ce:source-text": "Mondoulet L, Dioszeghy V, Vanoirbeek JA, Nemery B, Dupont C, Benhamou PH. Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts. Int Arch Allergy Immunol. 2011;154:299-309."
                    },
                    {
                        "ref-fulltext": "Esposito S, Isidori C, Pacitto A, et al. Epicutaneous immunotherapy in rhino-conjunctivitis and food allergies: A review of the literature. J Transl Med. 2018;16:329.",
                        "@id": "60",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Epicutaneous immunotherapy in rhino-conjunctivitis and food allergies: A review of the literature"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0060",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85057284522",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {"@first": "329"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Esposito",
                                        "ce:indexed-name": "Esposito S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Isidori",
                                        "ce:indexed-name": "Isidori C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Pacitto",
                                        "ce:indexed-name": "Pacitto A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Transl Med"
                        },
                        "ce:source-text": "Esposito S, Isidori C, Pacitto A, et al. Epicutaneous immunotherapy in rhino-conjunctivitis and food allergies: A review of the literature. J Transl Med. 2018;16:329."
                    },
                    {
                        "ref-fulltext": "Wang J, Sampson HA. Safety and efficacy of epicutaneous immunotherapy for food allergy. Pediatr Allergy Immunol. 2018;29:341-349.",
                        "@id": "61",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Safety and efficacy of epicutaneous immunotherapy for food allergy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0061",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85042556612",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "341",
                                    "@last": "349"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Sampson",
                                    "ce:indexed-name": "Sampson H.A."
                                }
                            ]},
                            "ref-sourcetitle": "Pediatr Allergy Immunol"
                        },
                        "ce:source-text": "Wang J, Sampson HA. Safety and efficacy of epicutaneous immunotherapy for food allergy. Pediatr Allergy Immunol. 2018;29:341-349."
                    },
                    {
                        "ref-fulltext": "Jones SM, Sicherer SH, Burks AW, et al. Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults. J Allergy Clin Immunol. 2017;139:1242-1252.",
                        "@id": "62",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0062",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84992688744",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "139"},
                                "pagerange": {
                                    "@first": "1242",
                                    "@last": "1252"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Jones",
                                        "ce:indexed-name": "Jones S.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Sicherer",
                                        "ce:indexed-name": "Sicherer S.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Burks",
                                        "ce:indexed-name": "Burks A.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Jones SM, Sicherer SH, Burks AW, et al. Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults. J Allergy Clin Immunol. 2017;139:1242-1252."
                    },
                    {
                        "ref-fulltext": "Sampson HA, Shreffler WG, Yang WH, et al. Effect of varying doses of epicutaneous immunotherapy vs placebo on reaction to peanut protein exposure among patients with peanut sensitivity: a randomized clinical trial. JAMA. 2017;318:1798-1809.",
                        "@id": "63",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Effect of varying doses of epicutaneous immunotherapy vs placebo on reaction to peanut protein exposure among patients with peanut sensitivity: a randomized clinical trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0063",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85034661944",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "318"},
                                "pagerange": {
                                    "@first": "1798",
                                    "@last": "1809"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Sampson",
                                        "ce:indexed-name": "Sampson H.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Shreffler",
                                        "ce:indexed-name": "Shreffler W.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang W.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA"
                        },
                        "ce:source-text": "Sampson HA, Shreffler WG, Yang WH, et al. Effect of varying doses of epicutaneous immunotherapy vs placebo on reaction to peanut protein exposure among patients with peanut sensitivity: a randomized clinical trial. JAMA. 2017;318:1798-1809."
                    },
                    {
                        "ref-fulltext": "Koppelman SJ, Peillon A, Agbotounou W, Sampson HA, Martin L. Epicutaneous immunotherapy for peanut allergy modifies IgG4 responses to major peanut allergens. J Allergy Clin Immunol. 2019;143:1218-1221.",
                        "@id": "64",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Epicutaneous immunotherapy for peanut allergy modifies IgG4 responses to major peanut allergens"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0064",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85057582338",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "143"},
                                "pagerange": {
                                    "@first": "1218",
                                    "@last": "1221"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Koppelman",
                                    "ce:indexed-name": "Koppelman S.J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Peillon",
                                    "ce:indexed-name": "Peillon A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Agbotounou",
                                    "ce:indexed-name": "Agbotounou W."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "H.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Sampson",
                                    "ce:indexed-name": "Sampson H.A."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Martin",
                                    "ce:indexed-name": "Martin L."
                                }
                            ]},
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Koppelman SJ, Peillon A, Agbotounou W, Sampson HA, Martin L. Epicutaneous immunotherapy for peanut allergy modifies IgG4 responses to major peanut allergens. J Allergy Clin Immunol. 2019;143:1218-1221."
                    },
                    {
                        "ref-fulltext": "Yu Y, Kiran Kumar MN, Wu MX. Delivery of allergen powder for safe and effective epicutaneous immunotherapy. J Allergy Clin Immunol. 2019; 6749:31605-31607.",
                        "@id": "65",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Delivery of allergen powder for safe and effective epicutaneous immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0065",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85081666063",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6749"},
                                "pagerange": {
                                    "@first": "31605",
                                    "@last": "31607"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Yu",
                                    "ce:indexed-name": "Yu Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.N.",
                                    "@_fa": "true",
                                    "ce:surname": "Kiran Kumar",
                                    "ce:indexed-name": "Kiran Kumar M.N."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.X.",
                                    "@_fa": "true",
                                    "ce:surname": "Wu",
                                    "ce:indexed-name": "Wu M.X."
                                }
                            ]},
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Yu Y, Kiran Kumar MN, Wu MX. Delivery of allergen powder for safe and effective epicutaneous immunotherapy. J Allergy Clin Immunol. 2019; 6749:31605-31607."
                    },
                    {
                        "ref-fulltext": "Jensen-Jarolim E, Bachmann M, Bonini S, et al. State-of-the-art in marketed adjuvants and formulations in allergen immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 2019. https://doi.org/10.1111/all.14134",
                        "@id": "66",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1111/all.14134",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "State-of-the-art in marketed adjuvants and formulations in allergen immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0066",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85081691527",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Jensen-Jarolim",
                                        "ce:indexed-name": "Jensen-Jarolim E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Bachmann",
                                        "ce:indexed-name": "Bachmann M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Bonini",
                                        "ce:indexed-name": "Bonini S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Jensen-Jarolim E, Bachmann M, Bonini S, et al. State-of-the-art in marketed adjuvants and formulations in allergen immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 2019. https://doi.org/10.1111/all.14134"
                    },
                    {
                        "ref-fulltext": "Wilcock LK, Francis JN, Durham SR. Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells. Clin Exp Allergy. 2004;34:1373-1378.",
                        "@id": "67",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0067",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "4544370248",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "34"},
                                "pagerange": {
                                    "@first": "1373",
                                    "@last": "1378"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Wilcock",
                                    "ce:indexed-name": "Wilcock L.K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.N.",
                                    "@_fa": "true",
                                    "ce:surname": "Francis",
                                    "ce:indexed-name": "Francis J.N."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Durham",
                                    "ce:indexed-name": "Durham S.R."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Exp Allergy"
                        },
                        "ce:source-text": "Wilcock LK, Francis JN, Durham SR. Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells. Clin Exp Allergy. 2004;34:1373-1378."
                    },
                    {
                        "ref-fulltext": "Exley C. Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy. Allergy Asthma Clin Immunol. 2014;10:4.",
                        "@id": "68",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0068",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84892860790",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {"@first": "4"}
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "ce:surname": "Exley",
                                "ce:indexed-name": "Exley C."
                            }]},
                            "ref-sourcetitle": "Allergy Asthma Clin Immunol"
                        },
                        "ce:source-text": "Exley C. Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy. Allergy Asthma Clin Immunol. 2014;10:4."
                    },
                    {
                        "ref-fulltext": "Roger A, Depreux N, Jurgens Y, Heath MD, Garcia G, Skinner MA. A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacy. Immun Inflamm Dis. 2014;2:92-98.",
                        "@id": "69",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0069",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84947920361",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2"},
                                "pagerange": {
                                    "@first": "92",
                                    "@last": "98"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Roger",
                                    "ce:indexed-name": "Roger A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Depreux",
                                    "ce:indexed-name": "Depreux N."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Jurgens",
                                    "ce:indexed-name": "Jurgens Y."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Heath",
                                    "ce:indexed-name": "Heath M.D."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Garcia",
                                    "ce:indexed-name": "Garcia G."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "M.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Skinner",
                                    "ce:indexed-name": "Skinner M.A."
                                }
                            ]},
                            "ref-sourcetitle": "Immun Inflamm Dis"
                        },
                        "ce:source-text": "Roger A, Depreux N, Jurgens Y, Heath MD, Garcia G, Skinner MA. A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacy. Immun Inflamm Dis. 2014;2:92-98."
                    },
                    {
                        "ref-fulltext": "Roberts G, Pfaar O, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018;73:765-798.",
                        "@id": "70",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0070",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85032825167",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "765",
                                    "@last": "798"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Roberts",
                                        "ce:indexed-name": "Roberts G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O.",
                                        "@_fa": "true",
                                        "ce:surname": "Pfaar",
                                        "ce:indexed-name": "Pfaar O."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Akdis",
                                        "ce:indexed-name": "Akdis C.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Roberts G, Pfaar O, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018;73:765-798."
                    },
                    {
                        "ref-fulltext": "Rosewich M, Lee DZielen S. Pollinex Quattro: An innovative four injections immunotherapy in allergic rhinitis. Hum Vaccin Immunother. 2013;9:1523-1531.",
                        "@id": "71",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Pollinex Quattro: An innovative four injections immunotherapy in allergic rhinitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0071",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84879933837",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "1523",
                                    "@last": "1531"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Rosewich",
                                    "ce:indexed-name": "Rosewich M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee Dzielen",
                                    "ce:indexed-name": "Lee Dzielen S."
                                }
                            ]},
                            "ref-sourcetitle": "Hum Vaccin Immunother"
                        },
                        "ce:source-text": "Rosewich M, Lee DZielen S. Pollinex Quattro: An innovative four injections immunotherapy in allergic rhinitis. Hum Vaccin Immunother. 2013;9:1523-1531."
                    },
                    {
                        "ref-fulltext": "Allergy Therapeutics announces top-line Phase III results from its B301 clinical trial. https://www.biospace.com/article/allergy-therapeutics-announces-top-line-phase-iii-results-from-its-b301-clinical-trial/. Accessed Mar 18, 2019.",
                        "@id": "72",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.biospace.com/article/allergy-therapeutics-announces-top-line-phase-iii-results-from-its-b301-clinical-trial/",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0072",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85081673488",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Accessed Mar 18, 2019",
                            "ref-sourcetitle": "Allergy Therapeutics announces top-line Phase III results from its B301 clinical trial"
                        },
                        "ce:source-text": "Allergy Therapeutics announces top-line Phase III results from its B301 clinical trial. https://www.biospace.com/article/allergy-therapeutics-announces-top-line-phase-iii-results-from-its-b301-clinical-trial/. Accessed Mar 18, 2019."
                    },
                    {
                        "ref-fulltext": "Pfaar O, Barth C, Jaschke C, HÃ¶rmann K, Klimek L. Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: A phase I/IIa study. Int Arch Allergy Immunol. 2011;154:336-344.",
                        "@id": "73",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: A phase I/IIa study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0073",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77958150039",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "154"},
                                "pagerange": {
                                    "@first": "336",
                                    "@last": "344"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "O.",
                                    "@_fa": "true",
                                    "ce:surname": "Pfaar",
                                    "ce:indexed-name": "Pfaar O."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Barth",
                                    "ce:indexed-name": "Barth C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Jaschke",
                                    "ce:indexed-name": "Jaschke C."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "HÃ¶rmann",
                                    "ce:indexed-name": "Hormann K."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Klimek",
                                    "ce:indexed-name": "Klimek L."
                                }
                            ]},
                            "ref-sourcetitle": "Int Arch Allergy Immunol"
                        },
                        "ce:source-text": "Pfaar O, Barth C, Jaschke C, HÃ¶rmann K, Klimek L. Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: A phase I/IIa study. Int Arch Allergy Immunol. 2011;154:336-344."
                    },
                    {
                        "ref-fulltext": "Patel P, Holdich T, Fischer von Weikersthal-Drachenberg KJ, Huber B. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen. J Allergy Clin Immunol. 2014;133:121-129.",
                        "@id": "74",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0074",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84891737215",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "133"},
                                "pagerange": {
                                    "@first": "121",
                                    "@last": "129"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Patel",
                                    "ce:indexed-name": "Patel P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Holdich",
                                    "ce:indexed-name": "Holdich T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Fischer von Weikersthal-Drachenberg",
                                    "ce:indexed-name": "Fischer von Weikersthal-Drachenberg K.J."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Huber",
                                    "ce:indexed-name": "Huber B."
                                }
                            ]},
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Patel P, Holdich T, Fischer von Weikersthal-Drachenberg KJ, Huber B. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen. J Allergy Clin Immunol. 2014;133:121-129."
                    },
                    {
                        "ref-fulltext": "Hufnagl K, Jensen-Jarolim E. Vitamin A and D in allergy: from experimental animal models and cellular studies to human disease. Allergo J Int. 2018;27:72-78.",
                        "@id": "75",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Vitamin A and D in allergy: from experimental animal models and cellular studies to human disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0075",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85049683087",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "72",
                                    "@last": "78"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Hufnagl",
                                    "ce:indexed-name": "Hufnagl K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Jensen-Jarolim",
                                    "ce:indexed-name": "Jensen-Jarolim E."
                                }
                            ]},
                            "ref-sourcetitle": "Allergo J Int"
                        },
                        "ce:source-text": "Hufnagl K, Jensen-Jarolim E. Vitamin A and D in allergy: from experimental animal models and cellular studies to human disease. Allergo J Int. 2018;27:72-78."
                    },
                    {
                        "ref-fulltext": "de Azevedo MS, Innocentin S, Dorella FA, et al. Immunotherapy of allergic diseases using probiotics or recombinant probiotics. J Appl Microbiol. 2013;115:319-333.",
                        "@id": "76",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Immunotherapy of allergic diseases using probiotics or recombinant probiotics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0076",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84880645433",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "115"},
                                "pagerange": {
                                    "@first": "319",
                                    "@last": "333"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.S.",
                                        "@_fa": "true",
                                        "ce:surname": "de Azevedo",
                                        "ce:indexed-name": "de Azevedo M.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Innocentin",
                                        "ce:indexed-name": "Innocentin S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Dorella",
                                        "ce:indexed-name": "Dorella F.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Appl Microbiol"
                        },
                        "ce:source-text": "de Azevedo MS, Innocentin S, Dorella FA, et al. Immunotherapy of allergic diseases using probiotics or recombinant probiotics. J Appl Microbiol. 2013;115:319-333."
                    },
                    {
                        "ref-fulltext": "Tang ML, Ponsonby AL, Orsini F, et al. Administration of a probiotic with peanut oral immunotherapy: a randomized trial. J Allergy Clin Immunol. 2015;135:737-744.",
                        "@id": "77",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Administration of a probiotic with peanut oral immunotherapy: a randomized trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0077",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84924618612",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "135"},
                                "pagerange": {
                                    "@first": "737",
                                    "@last": "744"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Tang",
                                        "ce:indexed-name": "Tang M.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Ponsonby",
                                        "ce:indexed-name": "Ponsonby A.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Orsini",
                                        "ce:indexed-name": "Orsini F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Tang ML, Ponsonby AL, Orsini F, et al. Administration of a probiotic with peanut oral immunotherapy: a randomized trial. J Allergy Clin Immunol. 2015;135:737-744."
                    },
                    {
                        "ref-fulltext": "Hsiao KC, Ponsonby AL, Axelrad C, Pitkin S, Tang MLK. PPOIT Study Team. Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial. Lancet Child Adolesc Health. 2017;1:97-105.",
                        "@id": "78",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "PPOIT Study Team. Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0078",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85029166480",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1"},
                                "pagerange": {
                                    "@first": "97",
                                    "@last": "105"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Hsiao",
                                    "ce:indexed-name": "Hsiao K.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Ponsonby",
                                    "ce:indexed-name": "Ponsonby A.L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Axelrad",
                                    "ce:indexed-name": "Axelrad C."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Pitkin",
                                    "ce:indexed-name": "Pitkin S."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M.L.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Tang",
                                    "ce:indexed-name": "Tang M.L.K."
                                }
                            ]},
                            "ref-sourcetitle": "Lancet Child Adolesc Health"
                        },
                        "ce:source-text": "Hsiao KC, Ponsonby AL, Axelrad C, Pitkin S, Tang MLK. PPOIT Study Team. Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial. Lancet Child Adolesc Health. 2017;1:97-105."
                    },
                    {
                        "ref-fulltext": "Jerzynska J, Stelmach W, Rychlik B, LechaÅska J, Podlecka D, Stelmach I. The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy Asthma Proc. 2016;37:105-114.",
                        "@id": "79",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0079",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84959468218",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "105",
                                    "@last": "114"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Jerzynska",
                                    "ce:indexed-name": "Jerzynska J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Stelmach",
                                    "ce:indexed-name": "Stelmach W."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Rychlik",
                                    "ce:indexed-name": "Rychlik B."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "LechaÅska",
                                    "ce:indexed-name": "Lechanska J."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Podlecka",
                                    "ce:indexed-name": "Podlecka D."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Stelmach",
                                    "ce:indexed-name": "Stelmach I."
                                }
                            ]},
                            "ref-sourcetitle": "Allergy Asthma Proc"
                        },
                        "ce:source-text": "Jerzynska J, Stelmach W, Rychlik B, LechaÅska J, Podlecka D, Stelmach I. The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy Asthma Proc. 2016;37:105-114."
                    },
                    {
                        "ref-fulltext": "Jerzynska J, Stelmach W, Balcerak J, et al. Effect of Lactobacillus rhamnosus GG and vitamin D supplementation on the immunologic effectiveness of grass-specific sublingual immunotherapy in children with allergy. Allergy Asthma Proc. 2016;37:324-334.",
                        "@id": "80",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Effect of Lactobacillus rhamnosus GG and vitamin D supplementation on the immunologic effectiveness of grass-specific sublingual immunotherapy in children with allergy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0080",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84978864782",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "324",
                                    "@last": "334"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Jerzynska",
                                        "ce:indexed-name": "Jerzynska J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Stelmach",
                                        "ce:indexed-name": "Stelmach W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Balcerak",
                                        "ce:indexed-name": "Balcerak J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy Asthma Proc"
                        },
                        "ce:source-text": "Jerzynska J, Stelmach W, Balcerak J, et al. Effect of Lactobacillus rhamnosus GG and vitamin D supplementation on the immunologic effectiveness of grass-specific sublingual immunotherapy in children with allergy. Allergy Asthma Proc. 2016;37:324-334."
                    },
                    {
                        "ref-fulltext": "Tighe H, Takabayashi K, Schwartz D, et al. Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol. 2000;106:124-134.",
                        "@id": "81",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0081",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0343953087",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "106"},
                                "pagerange": {
                                    "@first": "124",
                                    "@last": "134"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Tighe",
                                        "ce:indexed-name": "Tighe H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Takabayashi",
                                        "ce:indexed-name": "Takabayashi K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Schwartz",
                                        "ce:indexed-name": "Schwartz D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Tighe H, Takabayashi K, Schwartz D, et al. Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol. 2000;106:124-134."
                    },
                    {
                        "ref-fulltext": "Yu JE, Sicherer SH. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. Pediatrics. 2007;120:1445-1455.",
                        "@id": "82",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0082",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85081655335",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "120"},
                                "pagerange": {
                                    "@first": "1445",
                                    "@last": "1455"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Yu",
                                    "ce:indexed-name": "Yu J.E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Sicherer",
                                    "ce:indexed-name": "Sicherer S.H."
                                }
                            ]},
                            "ref-sourcetitle": "Pediatrics"
                        },
                        "ce:source-text": "Yu JE, Sicherer SH. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. Pediatrics. 2007;120:1445-1455."
                    },
                    {
                        "ref-fulltext": "Dynavax TOLAMBA(TM) Chamber Study Misses Primary Endpoint; Company Updates 2008 Financial Outlook. http://investors.dynavax.com/news-releases/news-release-details/dynavax-tolambatm-chamber-study-misses-primary-endpoint-company. Accessed May 16, 2008.",
                        "@id": "83",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "http://investors.dynavax.com/news-releases/news-release-details/dynavax-tolambatm-chamber-study-misses-primary-endpoint-company",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0083",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85081665666",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Accessed May 16, 2008",
                            "ref-sourcetitle": "Dynavax TOLAMBA(TM) Chamber Study Misses Primary Endpoint; Company Updates 2008 Financial Outlook"
                        },
                        "ce:source-text": "Dynavax TOLAMBA(TM) Chamber Study Misses Primary Endpoint; Company Updates 2008 Financial Outlook. http://investors.dynavax.com/news-releases/news-release-details/dynavax-tolambatm-chamber-study-misses-primary-endpoint-company. Accessed May 16, 2008."
                    },
                    {
                        "ref-fulltext": "SchÃ¼lke S, Burggraf M, Waibler Z, et al. A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy. J Allergy Clin Immunol. 2011;128:1340-1348.",
                        "@id": "84",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0084",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "82555167031",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "128"},
                                "pagerange": {
                                    "@first": "1340",
                                    "@last": "1348"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "SchÃ¼lke",
                                        "ce:indexed-name": "Schulke S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Burggraf",
                                        "ce:indexed-name": "Burggraf M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Waibler",
                                        "ce:indexed-name": "Waibler Z."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "SchÃ¼lke S, Burggraf M, Waibler Z, et al. A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy. J Allergy Clin Immunol. 2011;128:1340-1348."
                    },
                    {
                        "ref-fulltext": "SchÃ¼lke S, Kuttich K, Wolfheimer S, et al. Conjugation of wildtype and hypoallergenic mugwort allergen Art v 1 to flagellin induces IL-10-DC and suppresses allergen-specific TH2-responses in vivo. Sci Rep. 2017;7:11782.",
                        "@id": "85",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Conjugation of wildtype and hypoallergenic mugwort allergen Art v 1 to flagellin induces IL-10-DC and suppresses allergen-specific TH2-responses in vivo"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0085",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85065036710",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "11782"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "SchÃ¼lke",
                                        "ce:indexed-name": "Schulke S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Kuttich",
                                        "ce:indexed-name": "Kuttich K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Wolfheimer",
                                        "ce:indexed-name": "Wolfheimer S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Sci Rep"
                        },
                        "ce:source-text": "SchÃ¼lke S, Kuttich K, Wolfheimer S, et al. Conjugation of wildtype and hypoallergenic mugwort allergen Art v 1 to flagellin induces IL-10-DC and suppresses allergen-specific TH2-responses in vivo. Sci Rep. 2017;7:11782."
                    },
                    {
                        "ref-fulltext": "KitzmÃ¼ller C, Kalser J, Mutschlechner S, et al. Fusion proteins of flagellin and the major birch pollen allergen Bet v 1 show enhanced immunogenicity, reduced allergenicity, and intrinsic adjuvanticity. J Allergy Clin Immunol. 2018;141:293-299.",
                        "@id": "86",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Fusion proteins of flagellin and the major birch pollen allergen Bet v 1 show enhanced immunogenicity, reduced allergenicity, and intrinsic adjuvanticity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0086",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85019544489",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "141"},
                                "pagerange": {
                                    "@first": "293",
                                    "@last": "299"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "KitzmÃ¼ller",
                                        "ce:indexed-name": "Kitzmuller C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Kalser",
                                        "ce:indexed-name": "Kalser J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Mutschlechner",
                                        "ce:indexed-name": "Mutschlechner S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "KitzmÃ¼ller C, Kalser J, Mutschlechner S, et al. Fusion proteins of flagellin and the major birch pollen allergen Bet v 1 show enhanced immunogenicity, reduced allergenicity, and intrinsic adjuvanticity. J Allergy Clin Immunol. 2018;141:293-299."
                    },
                    {
                        "ref-fulltext": "Sirvent S, Soria I, Cirauqui C, et al. Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1. J Allergy Clin Immunol. 2016;138:558-567.",
                        "@id": "87",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0087",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84975144041",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "138"},
                                "pagerange": {
                                    "@first": "558",
                                    "@last": "567"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Sirvent",
                                        "ce:indexed-name": "Sirvent S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Soria",
                                        "ce:indexed-name": "Soria I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Cirauqui",
                                        "ce:indexed-name": "Cirauqui C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Sirvent S, Soria I, Cirauqui C, et al. Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1. J Allergy Clin Immunol. 2016;138:558-567."
                    },
                    {
                        "ref-fulltext": "Bonertz A, Roberts GC, Hoefnagel M, et al. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products. Allergy. 2018;73:64-76.",
                        "@id": "88",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0088",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85028550076",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "64",
                                    "@last": "76"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Bonertz",
                                        "ce:indexed-name": "Bonertz A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Roberts",
                                        "ce:indexed-name": "Roberts G.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Hoefnagel",
                                        "ce:indexed-name": "Hoefnagel M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Bonertz A, Roberts GC, Hoefnagel M, et al. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products. Allergy. 2018;73:64-76."
                    },
                    {
                        "ref-fulltext": "Navarro S, Lazzari A, Kanda A, et al. Bystander immunotherapy as a strategy to control allergen-driven airway inflammation. Mucosal Immunol. 2015;8:841-851.",
                        "@id": "89",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Bystander immunotherapy as a strategy to control allergen-driven airway inflammation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0089",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84932602593",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "841",
                                    "@last": "851"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Navarro",
                                        "ce:indexed-name": "Navarro S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Lazzari",
                                        "ce:indexed-name": "Lazzari A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Kanda",
                                        "ce:indexed-name": "Kanda A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Mucosal Immunol"
                        },
                        "ce:source-text": "Navarro S, Lazzari A, Kanda A, et al. Bystander immunotherapy as a strategy to control allergen-driven airway inflammation. Mucosal Immunol. 2015;8:841-851."
                    },
                    {
                        "ref-fulltext": "Moldaver DM, Bharhani MS, Rudulier CD, Wattie J, Inman MD, LarchÃ© M. Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy. J Allergy Clin Immunol. 2019;143:1087-1099.",
                        "@id": "90",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0090",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85051050397",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "143"},
                                "pagerange": {
                                    "@first": "1087",
                                    "@last": "1099"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Moldaver",
                                    "ce:indexed-name": "Moldaver D.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Bharhani",
                                    "ce:indexed-name": "Bharhani M.S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Rudulier",
                                    "ce:indexed-name": "Rudulier C.D."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Wattie",
                                    "ce:indexed-name": "Wattie J."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Inman",
                                    "ce:indexed-name": "Inman M.D."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "LarchÃ©",
                                    "ce:indexed-name": "Larche M."
                                }
                            ]},
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Moldaver DM, Bharhani MS, Rudulier CD, Wattie J, Inman MD, LarchÃ© M. Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy. J Allergy Clin Immunol. 2019;143:1087-1099."
                    },
                    {
                        "ref-fulltext": "van Zelm MC, McKenzie CI, Varese N, Rolland JM, O'Hehir RE. Recent developments and highlights in immune monitoring of allergen immunotherapy. Allergy. 2019;74:2342-2354.",
                        "@id": "91",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Recent developments and highlights in immune monitoring of allergen immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0091",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85074749322",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "74"},
                                "pagerange": {
                                    "@first": "2342",
                                    "@last": "2354"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.C.",
                                    "@_fa": "true",
                                    "ce:surname": "van Zelm",
                                    "ce:indexed-name": "van Zelm M.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.I.",
                                    "@_fa": "true",
                                    "ce:surname": "McKenzie",
                                    "ce:indexed-name": "McKenzie C.I."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Varese",
                                    "ce:indexed-name": "Varese N."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Rolland",
                                    "ce:indexed-name": "Rolland J.M."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "R.E.",
                                    "@_fa": "true",
                                    "ce:surname": "O'Hehir",
                                    "ce:indexed-name": "O'Hehir R.E."
                                }
                            ]},
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "van Zelm MC, McKenzie CI, Varese N, Rolland JM, O'Hehir RE. Recent developments and highlights in immune monitoring of allergen immunotherapy. Allergy. 2019;74:2342-2354."
                    },
                    {
                        "ref-fulltext": "Shamji MH, LjÃ¸rring C, Francis JN, et al. Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy. Allergy. 2012;67:217-226.",
                        "@id": "92",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0092",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84855802799",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {
                                    "@first": "217",
                                    "@last": "226"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Shamji",
                                        "ce:indexed-name": "Shamji M.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "LjÃ¸rring",
                                        "ce:indexed-name": "Ljorring C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Francis",
                                        "ce:indexed-name": "Francis J.N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Shamji MH, LjÃ¸rring C, Francis JN, et al. Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy. Allergy. 2012;67:217-226."
                    },
                    {
                        "ref-fulltext": "Feng M, Su Q, Lai X, et al. Functional and immunoreactive levels of IgG4 correlate with clinical responses during the maintenance phase of house dust mite immunotherapy. J Immunol. 2018;200:3897-3904.",
                        "@id": "93",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Functional and immunoreactive levels of IgG4 correlate with clinical responses during the maintenance phase of house dust mite immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0093",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85048402631",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "200"},
                                "pagerange": {
                                    "@first": "3897",
                                    "@last": "3904"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Feng",
                                        "ce:indexed-name": "Feng M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Su",
                                        "ce:indexed-name": "Su Q."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Lai",
                                        "ce:indexed-name": "Lai X."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Immunol"
                        },
                        "ce:source-text": "Feng M, Su Q, Lai X, et al. Functional and immunoreactive levels of IgG4 correlate with clinical responses during the maintenance phase of house dust mite immunotherapy. J Immunol. 2018;200:3897-3904."
                    },
                    {
                        "ref-fulltext": "Orengo JM, Radin AR, Kamat V, et al. Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement. Nat Commun. 2018;9:1421.",
                        "@id": "94",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0094",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85045516635",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {"@first": "1421"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Orengo",
                                        "ce:indexed-name": "Orengo J.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Radin",
                                        "ce:indexed-name": "Radin A.R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Kamat",
                                        "ce:indexed-name": "Kamat V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Commun"
                        },
                        "ce:source-text": "Orengo JM, Radin AR, Kamat V, et al. Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement. Nat Commun. 2018;9:1421."
                    },
                    {
                        "ref-fulltext": "Huang X, Tsilochristou O, Perna S, et al. Evolution of the IgE and IgG repertoire to a comprehensive array of allergen molecules in the first decade of life. Allergy. 2018;73:421-430.",
                        "@id": "95",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Evolution of the IgE and IgG repertoire to a comprehensive array of allergen molecules in the first decade of life"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0095",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85031087590",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "421",
                                    "@last": "430"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang X."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O.",
                                        "@_fa": "true",
                                        "ce:surname": "Tsilochristou",
                                        "ce:indexed-name": "Tsilochristou O."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Perna",
                                        "ce:indexed-name": "Perna S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Huang X, Tsilochristou O, Perna S, et al. Evolution of the IgE and IgG repertoire to a comprehensive array of allergen molecules in the first decade of life. Allergy. 2018;73:421-430."
                    },
                    {
                        "ref-fulltext": "Posa D, Perna S, Resch Y, et al. Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life. J Allergy Clin Immunol. 2017;139:541-549.",
                        "@id": "96",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0096",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85002894020",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "139"},
                                "pagerange": {
                                    "@first": "541",
                                    "@last": "549"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Posa",
                                        "ce:indexed-name": "Posa D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Perna",
                                        "ce:indexed-name": "Perna S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Resch",
                                        "ce:indexed-name": "Resch Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Posa D, Perna S, Resch Y, et al. Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life. J Allergy Clin Immunol. 2017;139:541-549."
                    },
                    {
                        "ref-fulltext": "Zhernov Y, Curin M, Khaitov M, Karaulov A, Valenta R. Recombinant allergens for immunotherapy: state of the art. Curr Opin Allergy Clin Immunol. 2019;19:402-414.",
                        "@id": "97",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Recombinant allergens for immunotherapy: state of the art"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0097",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85069234796",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "402",
                                    "@last": "414"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhernov",
                                    "ce:indexed-name": "Zhernov Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Curin",
                                    "ce:indexed-name": "Curin M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Khaitov",
                                    "ce:indexed-name": "Khaitov M."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Karaulov",
                                    "ce:indexed-name": "Karaulov A."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Valenta",
                                    "ce:indexed-name": "Valenta R."
                                }
                            ]},
                            "ref-sourcetitle": "Curr Opin Allergy Clin Immunol"
                        },
                        "ce:source-text": "Zhernov Y, Curin M, Khaitov M, Karaulov A, Valenta R. Recombinant allergens for immunotherapy: state of the art. Curr Opin Allergy Clin Immunol. 2019;19:402-414."
                    },
                    {
                        "ref-fulltext": "Lupinek C, Hochwallner H, Johansson C, et al. Maternal allergen-specific IgG might protect the child against allergic sensitization. J Allergy Clin Immunol. 2019;144:536-548.",
                        "@id": "98",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Maternal allergen-specific IgG might protect the child against allergic sensitization"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0098",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85062467615",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "144"},
                                "pagerange": {
                                    "@first": "536",
                                    "@last": "548"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Lupinek",
                                        "ce:indexed-name": "Lupinek C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Hochwallner",
                                        "ce:indexed-name": "Hochwallner H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Johansson",
                                        "ce:indexed-name": "Johansson C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Lupinek C, Hochwallner H, Johansson C, et al. Maternal allergen-specific IgG might protect the child against allergic sensitization. J Allergy Clin Immunol. 2019;144:536-548."
                    },
                    {
                        "ref-fulltext": "Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol. 2005;116:608-613.",
                        "@id": "99",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Allergen-specific immunotherapy with recombinant grass pollen allergens"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0099",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "24644509434",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "116"},
                                "pagerange": {
                                    "@first": "608",
                                    "@last": "613"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Jutel",
                                    "ce:indexed-name": "Jutel M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Jaeger",
                                    "ce:indexed-name": "Jaeger L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Suck",
                                    "ce:indexed-name": "Suck R."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Meyer",
                                    "ce:indexed-name": "Meyer H."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Fiebig",
                                    "ce:indexed-name": "Fiebig H."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "O.",
                                    "@_fa": "true",
                                    "ce:surname": "Cromwell",
                                    "ce:indexed-name": "Cromwell O."
                                }
                            ]},
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol. 2005;116:608-613."
                    },
                    {
                        "ref-fulltext": "Klimek L, Schendzielorz P, Pinol R, Pfaar O. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study. Clin Exp Allergy. 2012;42:936-945.",
                        "@id": "100",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0100",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84865175753",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "42"},
                                "pagerange": {
                                    "@first": "936",
                                    "@last": "945"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Klimek",
                                    "ce:indexed-name": "Klimek L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Schendzielorz",
                                    "ce:indexed-name": "Schendzielorz P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Pinol",
                                    "ce:indexed-name": "Pinol R."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "O.",
                                    "@_fa": "true",
                                    "ce:surname": "Pfaar",
                                    "ce:indexed-name": "Pfaar O."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Exp Allergy"
                        },
                        "ce:source-text": "Klimek L, Schendzielorz P, Pinol R, Pfaar O. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study. Clin Exp Allergy. 2012;42:936-945."
                    },
                    {
                        "ref-fulltext": "Tabar AI, Prieto L, Alba P, et al. Double-blind, randomized, placebo-controlled trial of allergen-specific immunotherapy with the major allergen Alt a 1. J Allergy Clin Immunol. 2019;144:216-223.",
                        "@id": "101",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Double-blind, randomized, placebo-controlled trial of allergen-specific immunotherapy with the major allergen Alt a 1"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0101",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85064273538",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "144"},
                                "pagerange": {
                                    "@first": "216",
                                    "@last": "223"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.I.",
                                        "@_fa": "true",
                                        "ce:surname": "Tabar",
                                        "ce:indexed-name": "Tabar A.I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Prieto",
                                        "ce:indexed-name": "Prieto L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Alba",
                                        "ce:indexed-name": "Alba P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Tabar AI, Prieto L, Alba P, et al. Double-blind, randomized, placebo-controlled trial of allergen-specific immunotherapy with the major allergen Alt a 1. J Allergy Clin Immunol. 2019;144:216-223."
                    },
                    {
                        "ref-fulltext": "Fellrath JM, Kettner A, Dufour N, et al. Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial. J Allergy Clin Immunol. 2003;111:854-861.",
                        "@id": "102",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0102",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0037395291",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "111"},
                                "pagerange": {
                                    "@first": "854",
                                    "@last": "861"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Fellrath",
                                        "ce:indexed-name": "Fellrath J.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Kettner",
                                        "ce:indexed-name": "Kettner A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Dufour",
                                        "ce:indexed-name": "Dufour N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Fellrath JM, Kettner A, Dufour N, et al. Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial. J Allergy Clin Immunol. 2003;111:854-861."
                    },
                    {
                        "ref-fulltext": "Hafner RP, Salapatek A, Patel D, LarchÃ© M, Laidler P. Validation of peptide immunotherapy as a new approach in the treatment of allergic rhinoconjunctivitis: The clinical benefits of treatment with Amb a 1 derived T cell epitopes. J Allergy Clin Immunol. 2012;129:AB368.",
                        "@id": "103",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Validation of peptide immunotherapy as a new approach in the treatment of allergic rhinoconjunctivitis: The clinical benefits of treatment with Amb a 1 derived T cell epitopes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0103",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84889608898",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "129"},
                                "pagerange": {"@first": "AB368"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Hafner",
                                    "ce:indexed-name": "Hafner R.P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Salapatek",
                                    "ce:indexed-name": "Salapatek A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Patel",
                                    "ce:indexed-name": "Patel D."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "LarchÃ©",
                                    "ce:indexed-name": "Larche M."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Laidler",
                                    "ce:indexed-name": "Laidler P."
                                }
                            ]},
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "Hafner RP, Salapatek A, Patel D, LarchÃ© M, Laidler P. Validation of peptide immunotherapy as a new approach in the treatment of allergic rhinoconjunctivitis: The clinical benefits of treatment with Amb a 1 derived T cell epitopes. J Allergy Clin Immunol. 2012;129:AB368."
                    },
                    {
                        "ref-fulltext": "LarchÃ© M, Hickey P, Hebert J, Hafner R. Safety and tolerability of escalating doses of house dust mite- peptide antigen desensitization (HDM-PAD). J Allergy Clin Immunol. 2013;131:AB37.",
                        "@id": "104",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Safety and tolerability of escalating doses of house dust mite- peptide antigen desensitization (HDM-PAD)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0104",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84909635220",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "131"},
                                "pagerange": {"@first": "AB37"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "LarchÃ©",
                                    "ce:indexed-name": "Larche M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Hickey",
                                    "ce:indexed-name": "Hickey P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Hebert",
                                    "ce:indexed-name": "Hebert J."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Hafner",
                                    "ce:indexed-name": "Hafner R."
                                }
                            ]},
                            "ref-sourcetitle": "J Allergy Clin Immunol"
                        },
                        "ce:source-text": "LarchÃ© M, Hickey P, Hebert J, Hafner R. Safety and tolerability of escalating doses of house dust mite- peptide antigen desensitization (HDM-PAD). J Allergy Clin Immunol. 2013;131:AB37."
                    },
                    {
                        "ref-fulltext": "Meyer W, Narkus A, Salapatek AM, Hafner D. Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber. Allergy. 2013;68:724-731.",
                        "@id": "105",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cea13588-cit-0105",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84878090456",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "68"},
                                "pagerange": {
                                    "@first": "724",
                                    "@last": "731"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Meyer",
                                    "ce:indexed-name": "Meyer W."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Narkus",
                                    "ce:indexed-name": "Narkus A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Salapatek",
                                    "ce:indexed-name": "Salapatek A.M."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Hafner",
                                    "ce:indexed-name": "Hafner D."
                                }
                            ]},
                            "ref-sourcetitle": "Allergy"
                        },
                        "ce:source-text": "Meyer W, Narkus A, Salapatek AM, Hafner D. Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber. Allergy. 2013;68:724-731."
                    }
                ]
            }}
        }
    },
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85081667499",
        "dc:description": "Conventional allergen-specific immunotherapy (AIT), based on administrations of allergen extracts, represents up to now the unique protocol for the desensitization of allergic patients. Whereas the effectiveness of AIT was evidenced for the treatment of allergic rhinitis and allergic asthma, such strategy remains experimental for food allergies up to now. However, important issues are commonly associated with AIT as the quality of natural allergen extracts, the long duration and adverse side-effects which negatively affect successful desensitization together with the patient compliance. The rapid progression of molecular allergology made possible the quest of safer, shorter and more effective immunotherapeutic approaches. The aim of this review was to provide an update on these different innovative recombinant derivatives including their efficacy but also their limitations. Despite promising preclinical and early clinical studies, the absence of convincing data in large phase III trials precludes so far the translation of these immunotherapeutic candidates into the clinic.",
        "pubmed-id": "32078207",
        "prism:coverDate": "2020-05-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85081667499",
        "dc:creator": {"author": [{
            "ce:given-name": "Phornsiri",
            "preferred-name": {
                "ce:given-name": "Phornsiri",
                "ce:initials": "P.",
                "ce:surname": "Pechsrichuang",
                "ce:indexed-name": "Pechsrichuang P."
            },
            "@seq": "1",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Pechsrichuang",
            "@auid": "35345609300",
            "author-url": "https://api.elsevier.com/content/author/author_id/35345609300",
            "ce:indexed-name": "Pechsrichuang P."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85081667499"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85081667499&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85081667499&origin=inward"
            }
        ],
        "source-id": "20723",
        "citedby-count": "14",
        "prism:volume": "50",
        "subtype": "re",
        "dc:title": "Molecular approaches to allergen-specific immunotherapy: Are we so far from clinical implementation?",
        "openaccess": "0",
        "prism:issn": "13652222 09547894",
        "publishercopyright": "Â© 2020 John Wiley & Sons Ltd",
        "prism:issueIdentifier": "5",
        "subtypeDescription": "Review",
        "prism:publicationName": "Clinical and Experimental Allergy",
        "prism:pageRange": "543-557",
        "prism:endingPage": "557",
        "openaccessFlag": "false",
        "prism:doi": "10.1111/cea.13588",
        "prism:startingPage": "543",
        "dc:identifier": "SCOPUS_ID:85081667499",
        "dc:publisher": "Blackwell Publishing Ltdinfo@royensoc.co.uk"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Allergens",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Asthma",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Desensitization, Immunologic",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Food Hypersensitivity",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Rhinitis, Allergic",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "allergen-specific immunotherapy"
        },
        {
            "@_fa": "true",
            "$": "blocking antibodies"
        },
        {
            "@_fa": "true",
            "$": "clinical trial"
        },
        {
            "@_fa": "true",
            "$": "efficacy"
        },
        {
            "@_fa": "true",
            "$": "hypoallergenic"
        },
        {
            "@_fa": "true",
            "$": "recombinant derivatives"
        },
        {
            "@_fa": "true",
            "$": "safety"
        },
        {
            "@_fa": "true",
            "$": "Treg"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Phornsiri",
            "preferred-name": {
                "ce:given-name": "Phornsiri",
                "ce:initials": "P.",
                "ce:surname": "Pechsrichuang",
                "ce:indexed-name": "Pechsrichuang P."
            },
            "@seq": "1",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Pechsrichuang",
            "@auid": "35345609300",
            "author-url": "https://api.elsevier.com/content/author/author_id/35345609300",
            "ce:indexed-name": "Pechsrichuang P."
        },
        {
            "ce:given-name": "Alain",
            "preferred-name": {
                "ce:given-name": "Alain",
                "ce:initials": "A.",
                "ce:surname": "Jacquet",
                "ce:indexed-name": "Jacquet A."
            },
            "@seq": "2",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Jacquet",
            "@auid": "55161139100",
            "author-url": "https://api.elsevier.com/content/author/author_id/55161139100",
            "ce:indexed-name": "Jacquet A."
        }
    ]}
}}